1 in 200 people live with glaucoma.​

Glaucoma is a leading cause of irreversible vision loss and often progresses without noticeable symptoms until advanced stages. Early screening is constrained by dependence on specialist expertise and access to expensive diagnostic infrastructure, leading to delayed diagnosis and preventable vision loss.​

Medios HI enables glaucoma risk screening directly from retinal images at the point of care, by identifying early structural optic nerve changes. It supports timely identification and referral, helping prevent avoidable vision loss at scale.